With the opioid overdose epidemic claiming more than 175 lives every day, America is facing a dire public health crisis unlike any our generation has ever seen. Every sector of society – from the government to the healthcare system and the private sector – is feeling the effects of the opioid crisis, and every sector must commit to finding and utilizing collaborative solutions.
Telemedicine is one of those solutions. It offers an opportunity to connect those suffering from addiction to the highest standard of care—medication-assisted treatment (MAT), which combines medication and behavioral counseling, and is proven to enable more people into stable, long-term recovery. Telemedicine can help address the issue of access to care, but other barriers, including legal and regulatory challenges, persist and must be addressed before telemedicine can be fully implemented as a solution to the opioid crisis.
On Monday, April 30, 2018, we held a spotlight session focusing on the public policy, regulatory, and medical elements of the crisis and how together they help (and hinder) efforts to end the opioid epidemic. Experts discussed barriers to telemedicine adoption, regulations preventing prescribing across state lines, the work that must be done to expand treatment capacity, utilization of telemedicine to benefit both doctors and patients, and other pertinent topics.
- Garry Carneal, J.D., MA, President, Clear Health Partners
- Lipi Roy, MD, MPH, Clinical Assistant Professor, Department of Population Health, NYC Addiction Treatment Center
- Anne Woodbury, Executive Director, Advocates for Opioid Recovery
- David R. Zook, Chair, Faegre Baker Daniels Consulting
Watch the recording here.